The role of copper transporters in the development of resistance to Pt drugs
- 25 June 2004
- journal article
- review article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 98 (10) , 1607-1613
- https://doi.org/10.1016/j.jinorgbio.2004.05.006
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Biochemical Characterization of the Human Copper Transporter Ctr1Journal of Biological Chemistry, 2002
- Up-regulation of transporters of the MRP family by drugs and toxinsToxicology Letters, 2001
- Carrier-mediated uptake of cisplatin by the OK renal epithelial cell lineToxicology, 2000
- Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)FEBS Letters, 1999
- Isolation of a Novel Human Canalicular Multispecific Organic Anion Transporter, cMOAT2/MRP3, and Its Expression in Cisplatin-Resistant Cancer Cells with Decreased ATP-Dependent Drug TransportBiochemical and Biophysical Research Communications, 1998
- Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells.Journal of Clinical Investigation, 1995
- Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cellsBiochemical Journal, 1994
- Amelioration of Cisplatin Toxicity in Rat Renal Cortical Slices by Dithiothreitol In vitroHuman & Experimental Toxicology, 1994
- Potentiation of dna‐adduct formation and cytotoxicity of platinum‐containing drugs by low pHInternational Journal of Cancer, 1993
- Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsCancer Chemotherapy and Pharmacology, 1990